Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laria

Showing results (181-190 of 192) with videos related to

Pageof 20
Sort By:
Digestive Diseases and Sciences|July 6, 2013
Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel diseaseF Argüelles-Arias, L Castro-Laria, T Lobatón, et al.
Endoscopy International Open|February 3, 2021
Comparison of the Mayo Endoscopy Score and the Ulcerative Colitis Endoscopy Index of Severity and the Ulcerative Colitis Colonoscopy Index of SeverityMaría Belvis Jiménez, Pedro Hergueta-Delgado, Blas Gómez Rodríguez, et al.
Revista Espanola De Enfermedades Digestivas|October 15, 2020
Index of the Mayo Endoscopy and Ulcerative Colitis Endoscopy Index of Severity: are they equally valid?María Belvis Jiménez, Pedro Hergueta-Delgado, Blas José Gómez Rodríguez, et al.
Inflammatory Bowel Diseases|June 13, 2015
Prognosis of Patients with Ulcerative Colitis in Sustained Remission After Thiopurines WithdrawalEstefanía Moreno-Rincón, José Manuel Benítez, Francisco Javier Serrano-Ruiz, et al.
Actas Urologicas Espanolas|July 9, 2025
Acute toxicity of SBRT in localized prostate cancer: A Spanish multicenter studyS E Romero Zoghbi, F López Campos, D Sanz-Rosa, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 7, 2026
Biochemical control and 2-year tolerability following stereotactic body radiotherapy for localized prostate cancer: a multicenter study in SpainSigfredo Elias Romero Zoghbi, Fernando López Campos, Abrahams Ocanto, et al.
Journal of Crohn'S & Colitis|February 6, 2019
Prevalence and Factors Associated With Fatigue in Patients With Inflammatory Bowel Disease: A Multicentre StudyC Chavarría, M J Casanova, M Chaparro, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 4, 2026
Total neoadjuvant therapy for locally advanced rectal cancer in Spain: results from a national patterns-of-care survey by the SEOR-GI GroupSigfredo Elias Romero Zoghbi, Fernando López Campos, Abrahams Ocanto, et al.
Journal of Autoimmunity|October 2, 2021
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohortMariele Gatto, Francesca Saccon, Laura Andreoli, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 11, 2020
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life SettingMariele Gatto, Francesca Saccon, Margherita Zen, et al.
Pageof 20

Showing results (181-190 of 192) with videos related to

Sort By:
Pageof 20
Digestive Diseases and Sciences|July 6, 2013
Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel diseaseF Argüelles-Arias, L Castro-Laria, T Lobatón, et al.
Endoscopy International Open|February 3, 2021
Comparison of the Mayo Endoscopy Score and the Ulcerative Colitis Endoscopy Index of Severity and the Ulcerative Colitis Colonoscopy Index of SeverityMaría Belvis Jiménez, Pedro Hergueta-Delgado, Blas Gómez Rodríguez, et al.
Revista Espanola De Enfermedades Digestivas|October 15, 2020
Index of the Mayo Endoscopy and Ulcerative Colitis Endoscopy Index of Severity: are they equally valid?María Belvis Jiménez, Pedro Hergueta-Delgado, Blas José Gómez Rodríguez, et al.
Inflammatory Bowel Diseases|June 13, 2015
Prognosis of Patients with Ulcerative Colitis in Sustained Remission After Thiopurines WithdrawalEstefanía Moreno-Rincón, José Manuel Benítez, Francisco Javier Serrano-Ruiz, et al.
Actas Urologicas Espanolas|July 9, 2025
Acute toxicity of SBRT in localized prostate cancer: A Spanish multicenter studyS E Romero Zoghbi, F López Campos, D Sanz-Rosa, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 7, 2026
Biochemical control and 2-year tolerability following stereotactic body radiotherapy for localized prostate cancer: a multicenter study in SpainSigfredo Elias Romero Zoghbi, Fernando López Campos, Abrahams Ocanto, et al.
Journal of Crohn'S & Colitis|February 6, 2019
Prevalence and Factors Associated With Fatigue in Patients With Inflammatory Bowel Disease: A Multicentre StudyC Chavarría, M J Casanova, M Chaparro, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 4, 2026
Total neoadjuvant therapy for locally advanced rectal cancer in Spain: results from a national patterns-of-care survey by the SEOR-GI GroupSigfredo Elias Romero Zoghbi, Fernando López Campos, Abrahams Ocanto, et al.
Journal of Autoimmunity|October 2, 2021
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohortMariele Gatto, Francesca Saccon, Laura Andreoli, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 11, 2020
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life SettingMariele Gatto, Francesca Saccon, Margherita Zen, et al.
Pageof 20